COVID-19 is a severe respiratory disease caused by the newly identified human coronavirus (HCoV) Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The virus was discovered in December 2019, and in March 2020, the disease was declared a global pandemic by the World Health Organization (WHO) due to a high number of cases. Although SARS-CoV-2 primarily affects the respiratory system, several studies have reported neurological complications in COVID-19 patients. Headache, dizziness, loss of taste and smell, encephalitis, encephalopathy, and cerebrovascular diseases are the most common neurological complications that are associated with COVID-19. In addition, seizures, neuromuscular junctions’ disorders, and Guillain–Barré syndrome were reported as complications of COVID-19, as well as neurodegenerative and demyelinating disorders. However, the management of these conditions remains a challenge. In this review, we discuss the prevalence, pathogenesis, and mechanisms of these neurological sequelae that are secondary to SARS-CoV-2 infection. We aim to update neurologists and healthcare workers on the possible neurological complications associated with COVID-19 and the management of these disease conditions.
【저자키워드】 COVID-19, SARS-CoV-2, stroke, headache, Encephalitis, management, Guillain–Barré syndrome, Encephalopathy, neurological, Seizures, cerebrovascular, Dizziness, myalgia, 【초록키워드】 coronavirus, Pathogenesis, SARS-COV-2 infection, virus, healthcare worker, global pandemic, Prevalence, WHO, Respiratory system, respiratory, disease, mechanism, COVID-19 patients, Guillain–Barrè syndrome, Cerebrovascular disease, Neurological complication, World Health Organization, disorders, severe respiratory disease, loss of taste, complications of COVID-19, Affect, caused, reported, addition, the disease, condition, conditions, neurodegenerative, with COVID-19, 【제목키워드】 Complication,